Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.

Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.
复制标题

DOI:
10.1186/s40364-022-00415-y
复制
发表时间:
2022-09-14
期刊:
影响因子:
11.1
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

干扰素-α2b(IFN-α2b)是属于干扰素-α(IFN-α)家族的一种高活性细胞因子。IFN-α2b具有有益的抗病毒、抗肿瘤、抗寄生虫和免疫调节活性。在某些癌症中,IFN-α2b的直接和间接抗增殖作用通过多种途径发生,主要是JAK-STAT途径。本文就IFN-α2b的作用机制和临床试验作一综述。本文还综述了IFN-α2b功能的潜在调节剂,这些调节剂可用于缓解IFN-α2b的不良反应。IFN-α2b不仅可以增强全身免疫应答,还可以直接杀死肿瘤细胞。IFN-α2b激活的JAK-STAT通路的不同部分,如干扰素α和β受体(IFNARs)、Janus激酶(JAKs)和IFN刺激的基因因子3(ISGF 3),可能是增强IFN-α2b药理作用的潜在靶点。尽管仍有一些问题有待解决,但根据目前的证据,IFN-α2b可以抑制疾病进展并改善某些类型恶性肿瘤患者的生存率。应作出更大努力,处理潜在的不利影响和并发症。
Interferon-α2b (IFN-α2b) is a highly active cytokine that belongs to the interferon-α (IFN-α) family. IFN-α2b has beneficial antiviral, antitumour, antiparasitic and immunomodulatory activities. Direct and indirect antiproliferative effects of IFN-α2b have been found to occur via multiple pathways, mainly the JAK-STAT pathway, in certain cancers. This article reviews mechanistic studies and clinical trials on IFN-α2b. Potential regulators of the function of IFN-α2b were also reviewed, which could be utilized to relieve the poor response to IFN-α2b. IFN-α2b can function not only by enhancing the systematic immune response but also by directly killing tumour cells. Different parts of JAK-STAT pathway activated by IFN-α2b, such as interferon alpha and beta receptors (IFNARs), Janus kinases (JAKs) and IFN‐stimulated gene factor 3 (ISGF3), might serve as potential target for enhancing the pharmacological action of IFN-α2b. Despite some issues that remain to be solved, based on current evidence, IFN-α2b can inhibit disease progression and improve the survival of patients with certain types of malignant tumours. More efforts should be made to address potential adverse effects and complications.
DOI: 10.1038/sj.cgt.7700364
发表时间: 2001-10-01
影响因子: 6.4
作者:
Ahmed, CMI;Johnson, DE;Sugarman, BJ
通讯作者: Sugarman, BJ
DOI: 10.1053/jhep.2002.32099
发表时间: 2002-04-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Alvarez, M;Cerliani, JP;Carrillo, MC
通讯作者: Carrillo, MC
DOI: 10.1172/jci.insight.120750
发表时间: 2018-09-06
期刊: JCI INSIGHT
影响因子: 8
作者:
Burgo, Melody Abikhair;Roudiani, Nazanin;Carucci, John A.
通讯作者: Carucci, John A.
DOI: 10.1038/s41467-021-22033-2
发表时间: 2021-03-19
影响因子: 16.6
作者:
Alicea-Torres K;Sanseviero E;Gui J;Chen J;Veglia F;Yu Q;Donthireddy L;Kossenkov A;Lin C;Fu S;Mulligan C;Nam B;Masters G;Denstman F;Bennett J;Hockstein N;Rynda-Apple A;Nefedova Y;Fuchs SY;Gabrilovich DI
通讯作者: Gabrilovich DI
DOI: 10.3322/caac.21640
发表时间: 2020-11-06
影响因子: 254.7
作者:
Byrd, David R.;Brierley, James D.;Gress, Donna M.
通讯作者: Gress, Donna M.